Table of Content

1 Study Coverage
1.1 Gabapentin Drug Product Introduction
1.2 Market by Type
1.2.1 Global Gabapentin Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Oral Solution
1.3 Market by Application
1.3.1 Global Gabapentin Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Postherpetic Neuralgia in Adults
1.3.3 Partial Onset Seizures
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gabapentin Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Gabapentin Drug Revenue by Region
2.2.1 Global Gabapentin Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Gabapentin Drug Revenue by Region (2018-2024)
2.2.3 Global Gabapentin Drug Revenue by Region (2024-2029)
2.2.4 Global Gabapentin Drug Revenue Market Share by Region (2018-2029)
2.3 Global Gabapentin Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Gabapentin Drug Sales by Region
2.4.1 Global Gabapentin Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Gabapentin Drug Sales by Region (2018-2024)
2.4.3 Global Gabapentin Drug Sales by Region (2024-2029)
2.4.4 Global Gabapentin Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Gabapentin Drug Sales by Manufacturers
3.1.1 Global Gabapentin Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Gabapentin Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gabapentin Drug in 2022
3.2 Global Gabapentin Drug Revenue by Manufacturers
3.2.1 Global Gabapentin Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Gabapentin Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Gabapentin Drug Revenue in 2022
3.3 Global Key Players of Gabapentin Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Gabapentin Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Gabapentin Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Gabapentin Drug, Product Offered and Application
3.8 Global Key Manufacturers of Gabapentin Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Gabapentin Drug Sales by Type
4.1.1 Global Gabapentin Drug Historical Sales by Type (2018-2024)
4.1.2 Global Gabapentin Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Gabapentin Drug Sales Market Share by Type (2018-2029)
4.2 Global Gabapentin Drug Revenue by Type
4.2.1 Global Gabapentin Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Gabapentin Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Gabapentin Drug Revenue Market Share by Type (2018-2029)
4.3 Global Gabapentin Drug Price by Type
4.3.1 Global Gabapentin Drug Price by Type (2018-2024)
4.3.2 Global Gabapentin Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Gabapentin Drug Sales by Application
5.1.1 Global Gabapentin Drug Historical Sales by Application (2018-2024)
5.1.2 Global Gabapentin Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Gabapentin Drug Sales Market Share by Application (2018-2029)
5.2 Global Gabapentin Drug Revenue by Application
5.2.1 Global Gabapentin Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Gabapentin Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Gabapentin Drug Revenue Market Share by Application (2018-2029)
5.3 Global Gabapentin Drug Price by Application
5.3.1 Global Gabapentin Drug Price by Application (2018-2024)
5.3.2 Global Gabapentin Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Gabapentin Drug Market Size by Type
6.1.1 US & Canada Gabapentin Drug Sales by Type (2018-2029)
6.1.2 US & Canada Gabapentin Drug Revenue by Type (2018-2029)
6.2 US & Canada Gabapentin Drug Market Size by Application
6.2.1 US & Canada Gabapentin Drug Sales by Application (2018-2029)
6.2.2 US & Canada Gabapentin Drug Revenue by Application (2018-2029)
6.3 US & Canada Gabapentin Drug Market Size by Country
6.3.1 US & Canada Gabapentin Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Gabapentin Drug Sales by Country (2018-2029)
6.3.3 US & Canada Gabapentin Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Gabapentin Drug Market Size by Type
7.1.1 Europe Gabapentin Drug Sales by Type (2018-2029)
7.1.2 Europe Gabapentin Drug Revenue by Type (2018-2029)
7.2 Europe Gabapentin Drug Market Size by Application
7.2.1 Europe Gabapentin Drug Sales by Application (2018-2029)
7.2.2 Europe Gabapentin Drug Revenue by Application (2018-2029)
7.3 Europe Gabapentin Drug Market Size by Country
7.3.1 Europe Gabapentin Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Gabapentin Drug Sales by Country (2018-2029)
7.3.3 Europe Gabapentin Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Gabapentin Drug Market Size
8.1.1 China Gabapentin Drug Sales (2018-2029)
8.1.2 China Gabapentin Drug Revenue (2018-2029)
8.2 China Gabapentin Drug Market Size by Application
8.2.1 China Gabapentin Drug Sales by Application (2018-2029)
8.2.2 China Gabapentin Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gabapentin Drug Market Size by Type
9.1.1 Asia Gabapentin Drug Sales by Type (2018-2029)
9.1.2 Asia Gabapentin Drug Revenue by Type (2018-2029)
9.2 Asia Gabapentin Drug Market Size by Application
9.2.1 Asia Gabapentin Drug Sales by Application (2018-2029)
9.2.2 Asia Gabapentin Drug Revenue by Application (2018-2029)
9.3 Asia Gabapentin Drug Sales by Region
9.3.1 Asia Gabapentin Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Gabapentin Drug Revenue by Region (2018-2029)
9.3.3 Asia Gabapentin Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Gabapentin Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Gabapentin Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Gabapentin Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Gabapentin Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Gabapentin Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Gabapentin Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Gabapentin Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Gabapentin Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Gabapentin Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Gabapentin Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Depomed
11.2.1 Depomed Company Information
11.2.2 Depomed Overview
11.2.3 Depomed Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Depomed Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Depomed Recent Developments
11.3 Apotex
11.3.1 Apotex Company Information
11.3.2 Apotex Overview
11.3.3 Apotex Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Apotex Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Apotex Recent Developments
11.4 Teva
11.4.1 Teva Company Information
11.4.2 Teva Overview
11.4.3 Teva Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Teva Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Acella Pharmaceuticals
11.5.1 Acella Pharmaceuticals Company Information
11.5.2 Acella Pharmaceuticals Overview
11.5.3 Acella Pharmaceuticals Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Acella Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Acella Pharmaceuticals Recent Developments
11.6 Taro
11.6.1 Taro Company Information
11.6.2 Taro Overview
11.6.3 Taro Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Taro Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Taro Recent Developments
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Information
11.7.2 Sun Pharmaceutical Overview
11.7.3 Sun Pharmaceutical Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Sun Pharmaceutical Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharmaceutical Recent Developments
11.8 Glenmark
11.8.1 Glenmark Company Information
11.8.2 Glenmark Overview
11.8.3 Glenmark Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Glenmark Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Glenmark Recent Developments
11.9 Amneal Pharmaceuticals
11.9.1 Amneal Pharmaceuticals Company Information
11.9.2 Amneal Pharmaceuticals Overview
11.9.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Amneal Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amneal Pharmaceuticals Recent Developments
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Information
11.10.2 Aurobindo Pharma Overview
11.10.3 Aurobindo Pharma Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Aurobindo Pharma Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Aurobindo Pharma Recent Developments
11.11 Zydus Pharmaceuticals
11.11.1 Zydus Pharmaceuticals Company Information
11.11.2 Zydus Pharmaceuticals Overview
11.11.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Zydus Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zydus Pharmaceuticals Recent Developments
11.12 Hi-Tech Pharmaceuticals
11.12.1 Hi-Tech Pharmaceuticals Company Information
11.12.2 Hi-Tech Pharmaceuticals Overview
11.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hi-Tech Pharmaceuticals Recent Developments
11.13 Marksans Pharma
11.13.1 Marksans Pharma Company Information
11.13.2 Marksans Pharma Overview
11.13.3 Marksans Pharma Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Marksans Pharma Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Marksans Pharma Recent Developments
11.14 Mylan
11.14.1 Mylan Company Information
11.14.2 Mylan Overview
11.14.3 Mylan Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Mylan Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Mylan Recent Developments
11.15 InvaGen Pharmaceuticals
11.15.1 InvaGen Pharmaceuticals Company Information
11.15.2 InvaGen Pharmaceuticals Overview
11.15.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 InvaGen Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 InvaGen Pharmaceuticals Recent Developments
11.16 Alkem Laboratories
11.16.1 Alkem Laboratories Company Information
11.16.2 Alkem Laboratories Overview
11.16.3 Alkem Laboratories Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Alkem Laboratories Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alkem Laboratories Recent Developments
11.17 Tris Pharma
11.17.1 Tris Pharma Company Information
11.17.2 Tris Pharma Overview
11.17.3 Tris Pharma Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Tris Pharma Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Tris Pharma Recent Developments
11.18 ACI HealthCare Limited
11.18.1 ACI HealthCare Limited Company Information
11.18.2 ACI HealthCare Limited Overview
11.18.3 ACI HealthCare Limited Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 ACI HealthCare Limited Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 ACI HealthCare Limited Recent Developments
11.19 Jiangsu Hengrui Medicine
11.19.1 Jiangsu Hengrui Medicine Company Information
11.19.2 Jiangsu Hengrui Medicine Overview
11.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Jiangsu Hengrui Medicine Recent Developments
11.20 CSPC Ouyi Pharmaceutical
11.20.1 CSPC Ouyi Pharmaceutical Company Information
11.20.2 CSPC Ouyi Pharmaceutical Overview
11.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 CSPC Ouyi Pharmaceutical Recent Developments
11.21 Sciegen Pharmaceuticals
11.21.1 Sciegen Pharmaceuticals Company Information
11.21.2 Sciegen Pharmaceuticals Overview
11.21.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 Sciegen Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Sciegen Pharmaceuticals Recent Developments
11.22 Epic Pharma
11.22.1 Epic Pharma Company Information
11.22.2 Epic Pharma Overview
11.22.3 Epic Pharma Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.22.4 Epic Pharma Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Epic Pharma Recent Developments
11.23 Lupin Limited
11.23.1 Lupin Limited Company Information
11.23.2 Lupin Limited Overview
11.23.3 Lupin Limited Gabapentin Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.23.4 Lupin Limited Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Lupin Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gabapentin Drug Industry Chain Analysis
12.2 Gabapentin Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gabapentin Drug Production Mode & Process
12.4 Gabapentin Drug Sales and Marketing
12.4.1 Gabapentin Drug Sales Channels
12.4.2 Gabapentin Drug Distributors
12.5 Gabapentin Drug Customers
13 Market Dynamics
13.1 Gabapentin Drug Industry Trends
13.2 Gabapentin Drug Market Drivers
13.3 Gabapentin Drug Market Challenges
13.4 Gabapentin Drug Market Restraints
14 Key Findings in The Global Gabapentin Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gabapentin Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Tablet
Table 4. Major Manufacturers of Oral Solution
Table 5. Global Gabapentin Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Gabapentin Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Gabapentin Drug Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Gabapentin Drug Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Gabapentin Drug Revenue Market Share by Region (2018-2024)
Table 10. Global Gabapentin Drug Revenue Market Share by Region (2024-2029)
Table 11. Global Gabapentin Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Gabapentin Drug Sales by Region (2018-2024) & (K Units)
Table 13. Global Gabapentin Drug Sales by Region (2024-2029) & (K Units)
Table 14. Global Gabapentin Drug Sales Market Share by Region (2018-2024)
Table 15. Global Gabapentin Drug Sales Market Share by Region (2024-2029)
Table 16. Global Gabapentin Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Gabapentin Drug Sales Share by Manufacturers (2018-2024)
Table 18. Global Gabapentin Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Gabapentin Drug Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Gabapentin Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Gabapentin Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Gabapentin Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Gabapentin Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Drug as of 2022)
Table 24. Global Key Manufacturers of Gabapentin Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Gabapentin Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Gabapentin Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Gabapentin Drug Sales by Type (2018-2024) & (K Units)
Table 29. Global Gabapentin Drug Sales by Type (2024-2029) & (K Units)
Table 30. Global Gabapentin Drug Sales Share by Type (2018-2024)
Table 31. Global Gabapentin Drug Sales Share by Type (2024-2029)
Table 32. Global Gabapentin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Gabapentin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Gabapentin Drug Revenue Share by Type (2018-2024)
Table 35. Global Gabapentin Drug Revenue Share by Type (2024-2029)
Table 36. Gabapentin Drug Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Gabapentin Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Gabapentin Drug Sales by Application (2018-2024) & (K Units)
Table 39. Global Gabapentin Drug Sales by Application (2024-2029) & (K Units)
Table 40. Global Gabapentin Drug Sales Share by Application (2018-2024)
Table 41. Global Gabapentin Drug Sales Share by Application (2024-2029)
Table 42. Global Gabapentin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Gabapentin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Gabapentin Drug Revenue Share by Application (2018-2024)
Table 45. Global Gabapentin Drug Revenue Share by Application (2024-2029)
Table 46. Gabapentin Drug Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Gabapentin Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Gabapentin Drug Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Gabapentin Drug Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Gabapentin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Gabapentin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Gabapentin Drug Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Gabapentin Drug Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Gabapentin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Gabapentin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Gabapentin Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Gabapentin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Gabapentin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 61. Europe Gabapentin Drug Sales by Type (2018-2024) & (K Units)
Table 62. Europe Gabapentin Drug Sales by Type (2024-2029) & (K Units)
Table 63. Europe Gabapentin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Gabapentin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Gabapentin Drug Sales by Application (2018-2024) & (K Units)
Table 66. Europe Gabapentin Drug Sales by Application (2024-2029) & (K Units)
Table 67. Europe Gabapentin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Gabapentin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Gabapentin Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Gabapentin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Gabapentin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 73. Europe Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 74. China Gabapentin Drug Sales by Type (2018-2024) & (K Units)
Table 75. China Gabapentin Drug Sales by Type (2024-2029) & (K Units)
Table 76. China Gabapentin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Gabapentin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Gabapentin Drug Sales by Application (2018-2024) & (K Units)
Table 79. China Gabapentin Drug Sales by Application (2024-2029) & (K Units)
Table 80. China Gabapentin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Gabapentin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Gabapentin Drug Sales by Type (2018-2024) & (K Units)
Table 83. Asia Gabapentin Drug Sales by Type (2024-2029) & (K Units)
Table 84. Asia Gabapentin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Gabapentin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Gabapentin Drug Sales by Application (2018-2024) & (K Units)
Table 87. Asia Gabapentin Drug Sales by Application (2024-2029) & (K Units)
Table 88. Asia Gabapentin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Gabapentin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Gabapentin Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Gabapentin Drug Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Gabapentin Drug Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Gabapentin Drug Sales by Region (2018-2024) & (K Units)
Table 94. Asia Gabapentin Drug Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Gabapentin Drug Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Gabapentin Drug Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Gabapentin Drug Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Gabapentin Drug Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Gabapentin Drug Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Gabapentin Drug Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Gabapentin Drug Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Gabapentin Drug Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Gabapentin Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Gabapentin Drug Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Gabapentin Drug Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Gabapentin Drug Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Gabapentin Drug Sales by Country (2024-2029) & (K Units)
Table 108. Pfizer Company Information
Table 109. Pfizer Description and Major Businesses
Table 110. Pfizer Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Pfizer Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Pfizer Recent Developments
Table 113. Depomed Company Information
Table 114. Depomed Description and Major Businesses
Table 115. Depomed Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Depomed Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Depomed Recent Developments
Table 118. Apotex Company Information
Table 119. Apotex Description and Major Businesses
Table 120. Apotex Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Apotex Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Apotex Recent Developments
Table 123. Teva Company Information
Table 124. Teva Description and Major Businesses
Table 125. Teva Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Teva Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Teva Recent Developments
Table 128. Acella Pharmaceuticals Company Information
Table 129. Acella Pharmaceuticals Description and Major Businesses
Table 130. Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Acella Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Acella Pharmaceuticals Recent Developments
Table 133. Taro Company Information
Table 134. Taro Description and Major Businesses
Table 135. Taro Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Taro Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Taro Recent Developments
Table 138. Sun Pharmaceutical Company Information
Table 139. Sun Pharmaceutical Description and Major Businesses
Table 140. Sun Pharmaceutical Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Sun Pharmaceutical Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Sun Pharmaceutical Recent Developments
Table 143. Glenmark Company Information
Table 144. Glenmark Description and Major Businesses
Table 145. Glenmark Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Glenmark Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Glenmark Recent Developments
Table 148. Amneal Pharmaceuticals Company Information
Table 149. Amneal Pharmaceuticals Description and Major Businesses
Table 150. Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Amneal Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Amneal Pharmaceuticals Recent Developments
Table 153. Aurobindo Pharma Company Information
Table 154. Aurobindo Pharma Description and Major Businesses
Table 155. Aurobindo Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Aurobindo Pharma Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Aurobindo Pharma Recent Developments
Table 158. Zydus Pharmaceuticals Company Information
Table 159. Zydus Pharmaceuticals Description and Major Businesses
Table 160. Zydus Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Zydus Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Zydus Pharmaceuticals Recent Developments
Table 163. Hi-Tech Pharmaceuticals Company Information
Table 164. Hi-Tech Pharmaceuticals Description and Major Businesses
Table 165. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Hi-Tech Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Hi-Tech Pharmaceuticals Recent Developments
Table 168. Marksans Pharma Company Information
Table 169. Marksans Pharma Description and Major Businesses
Table 170. Marksans Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Marksans Pharma Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Marksans Pharma Recent Developments
Table 173. Mylan Company Information
Table 174. Mylan Description and Major Businesses
Table 175. Mylan Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Mylan Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Mylan Recent Developments
Table 178. InvaGen Pharmaceuticals Company Information
Table 179. InvaGen Pharmaceuticals Description and Major Businesses
Table 180. InvaGen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. InvaGen Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. InvaGen Pharmaceuticals Recent Developments
Table 183. Alkem Laboratories Company Information
Table 184. Alkem Laboratories Description and Major Businesses
Table 185. Alkem Laboratories Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Alkem Laboratories Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Alkem Laboratories Recent Developments
Table 188. Tris Pharma Company Information
Table 189. Tris Pharma Description and Major Businesses
Table 190. Tris Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Tris Pharma Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Tris Pharma Recent Developments
Table 193. ACI HealthCare Limited Company Information
Table 194. ACI HealthCare Limited Description and Major Businesses
Table 195. ACI HealthCare Limited Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. ACI HealthCare Limited Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. ACI HealthCare Limited Recent Developments
Table 198. Jiangsu Hengrui Medicine Company Information
Table 199. Jiangsu Hengrui Medicine Description and Major Businesses
Table 200. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 201. Jiangsu Hengrui Medicine Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. Jiangsu Hengrui Medicine Recent Developments
Table 203. CSPC Ouyi Pharmaceutical Company Information
Table 204. CSPC Ouyi Pharmaceutical Description and Major Businesses
Table 205. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 206. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. CSPC Ouyi Pharmaceutical Recent Developments
Table 208. Sciegen Pharmaceuticals Company Information
Table 209. Sciegen Pharmaceuticals Description and Major Businesses
Table 210. Sciegen Pharmaceuticals Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 211. Sciegen Pharmaceuticals Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 212. Sciegen Pharmaceuticals Recent Developments
Table 213. Epic Pharma Company Information
Table 214. Epic Pharma Description and Major Businesses
Table 215. Epic Pharma Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 216. Epic Pharma Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 217. Epic Pharma Recent Developments
Table 218. Lupin Limited Company Information
Table 219. Lupin Limited Description and Major Businesses
Table 220. Lupin Limited Gabapentin Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 221. Lupin Limited Gabapentin Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 222. Lupin Limited Recent Developments
Table 223. Key Raw Materials Lists
Table 224. Raw Materials Key Suppliers Lists
Table 225. Gabapentin Drug Distributors List
Table 226. Gabapentin Drug Customers List
Table 227. Gabapentin Drug Market Trends
Table 228. Gabapentin Drug Market Drivers
Table 229. Gabapentin Drug Market Challenges
Table 230. Gabapentin Drug Market Restraints
Table 231. Research Programs/Design for This Report
Table 232. Key Data Information from Secondary Sources
Table 233. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Drug Product Picture
Figure 2. Global Gabapentin Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Gabapentin Drug Market Share by Type in 2022 & 2029
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Oral Solution Product Picture
Figure 7. Global Gabapentin Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Gabapentin Drug Market Share by Application in 2022 & 2029
Figure 9. Postherpetic Neuralgia in Adults
Figure 10. Partial Onset Seizures
Figure 11. Others
Figure 12. Gabapentin Drug Report Years Considered
Figure 13. Global Gabapentin Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gabapentin Drug Revenue 2018-2029 (US$ Million)
Figure 15. Global Gabapentin Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Gabapentin Drug Revenue Market Share by Region (2018-2029)
Figure 17. Global Gabapentin Drug Sales 2018-2029 ((K Units)
Figure 18. Global Gabapentin Drug Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Gabapentin Drug Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Gabapentin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Gabapentin Drug Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Gabapentin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Gabapentin Drug Sales YoY (2018-2029) & (K Units)
Figure 24. China Gabapentin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Gabapentin Drug Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Gabapentin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Gabapentin Drug Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Gabapentin Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Gabapentin Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Gabapentin Drug in the World: Market Share by Gabapentin Drug Revenue in 2022
Figure 31. Global Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Gabapentin Drug Sales Market Share by Type (2018-2029)
Figure 33. Global Gabapentin Drug Revenue Market Share by Type (2018-2029)
Figure 34. Global Gabapentin Drug Sales Market Share by Application (2018-2029)
Figure 35. Global Gabapentin Drug Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Gabapentin Drug Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Gabapentin Drug Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Gabapentin Drug Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Gabapentin Drug Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Gabapentin Drug Revenue Share by Country (2018-2029)
Figure 41. US & Canada Gabapentin Drug Sales Share by Country (2018-2029)
Figure 42. U.S. Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Gabapentin Drug Sales Market Share by Type (2018-2029)
Figure 45. Europe Gabapentin Drug Revenue Market Share by Type (2018-2029)
Figure 46. Europe Gabapentin Drug Sales Market Share by Application (2018-2029)
Figure 47. Europe Gabapentin Drug Revenue Market Share by Application (2018-2029)
Figure 48. Europe Gabapentin Drug Revenue Share by Country (2018-2029)
Figure 49. Europe Gabapentin Drug Sales Share by Country (2018-2029)
Figure 50. Germany Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 51. France Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 55. China Gabapentin Drug Sales Market Share by Type (2018-2029)
Figure 56. China Gabapentin Drug Revenue Market Share by Type (2018-2029)
Figure 57. China Gabapentin Drug Sales Market Share by Application (2018-2029)
Figure 58. China Gabapentin Drug Revenue Market Share by Application (2018-2029)
Figure 59. Asia Gabapentin Drug Sales Market Share by Type (2018-2029)
Figure 60. Asia Gabapentin Drug Revenue Market Share by Type (2018-2029)
Figure 61. Asia Gabapentin Drug Sales Market Share by Application (2018-2029)
Figure 62. Asia Gabapentin Drug Revenue Market Share by Application (2018-2029)
Figure 63. Asia Gabapentin Drug Revenue Share by Region (2018-2029)
Figure 64. Asia Gabapentin Drug Sales Share by Region (2018-2029)
Figure 65. Japan Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 69. India Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Gabapentin Drug Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Gabapentin Drug Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Gabapentin Drug Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Gabapentin Drug Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Gabapentin Drug Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Gabapentin Drug Sales Share by Country (2018-2029)
Figure 76. Brazil Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Gabapentin Drug Revenue (2018-2029) & (US$ Million)
Figure 81. Gabapentin Drug Value Chain
Figure 82. Gabapentin Drug Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed